Adimmune Corporation 2025 Q4 Financial Report
NQ Score
53/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Adimmune Corporation reported a basic EPS of -0.57 NTD and a net loss of 330 million NTD for Q4 2025, despite achieving operating revenue of 1.402 billion NTD.
AI analysis data is not yet available.